Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence



Rating:

Share or cite this content

Citations should be made in the following way:
G. Brusselle (Ghent, Belgium), N. Barnes (Brentford, Middlesex & London, United Kingdom), R. Buhl (Mainz, Germany), F. Gardiner (Brentford, Middlesex, United Kingdom), L. Heaney (Belfast, United Kingdom), H. Inoue (Kagoshima, Japan), G. Mosnaim (Evanston, IL, United States of America), A. Papi (Ferrara, Italy), E. Pizzichini (Brentford, Middlesex & Santa Catarina, United Kingdom), J. Tamaoki (Tokyo, Japan), C. Vogelmeier (Marburg, Germany), A. Zarankaite (Brentford, Middlesex, United Kingdom), I. Pavord (Oxford, United Kingdom). CAPTAIN: Relationship between FEV1 reversibility at screening as a continuous variable and treatment response. 3384

Member's Comments

No comment yet.

Related content which might interest you: CAPTAIN: Effects of lung function at screening (FEV1 % predicted) as a continuous variable on treatment outcomes Source: Virtual Congress 2021 – Asthma treatment: clinical and translational science Year: 2021 Correlation of various parameters with FEV1 in the assessment of asthma severity Source: Eur Respir J 2001; 18: Suppl. 33, 51s Year: 2001 Has the determination of the rate of decline of FEV1 added value in addition to the determination of FEV1/FVC and FEV1 Source: International Congress 2016 – Man versus machine: waves, frequency, and more in lung function Year: 2016 Natural decline in FEV1 and FVC: Self versus reference equations Source: Annual Congress 2013 –Reference, reliability and risk: advances in lung function Year: 2013 Exploring the clinical utility of measuring reversibility in mid expiratory flow and its relationship with FEV1 reversibility in patients with asthma. Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 Spirometry parameters and adherence to COPD treatment:  is there association? Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020 Spirometric changes in bronchodilation tests as predictors of asthma diagnosis and treatment response in patients with FEV1 =80% predicted Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 The ratio of inspiratory ΣRrs to expiratory ΣRrs measured by forced oscillation technique correlates with the parameters reflecting narrowing of small airway measured by spirometry in patients with mild to moderate COPD Source: Annual Congress 2013 –New issues in lung function testing Year: 2013 Comparison of the asthma control test and % predicted FEV1 in relation to correlation with physicians assessment of asthma control and treatment decisions Source: Annual Congress 2011 - Update on monitoring airway diseases Year: 2011 Fixed ratio or lower limit of normal for the FEV1/VC ratio: Relation to symptoms and extended lung function tests Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population Year: 2013 The relationship between peak expiratory flow rate (PEFR) and forced expiratroy volume in the first second (FEV1) at low levels of FEV1. Implications for the assessment of COPD (chronic obstructive pulmonary disease) in primary care Source: Eur Respir J 2002; 20: Suppl. 38, 397s Year: 2002 Dose omission to shorten methacholine challenge testing: clinical consequences and safety of the use of a "10% fall in FEV1" threshold Source: International Congress 2018 – New methods and concepts in tests of lung and respiratory muscle function Year: 2018 Changes in forced oscillatory parameters in reversibility testing as predictors for cough variant asthma Source: International Congress 2018 – Asthma management Year: 2018 Relationship of baseline or annual change of clinical parameters on mortality in patients with COPD Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013 Relationship between baseline rescue medication use and reductions in COPD exacerbation rates: a subgroup analysis of the ETHOS trial Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies Year: 2021 Increase in oxygen uptake to work rate increment (ΔVO2/ΔWR) during cardiopulmonary exercise testing: Correlation to COPD severity indicators, including BODE index Source: International Congress 2015 – Pathophysiological mechanisms at different scales: lung, airways, muscles and symptom perception Year: 2015 Differences in functional impairment diagnosis using global lung initiative (GLI) predictive values for spirometry Source: International Congress 2014 – The impact of the Global Lung Initiative (GLI) reference equations and spirometry quality in all ages Year: 2014 How often FEV1 underestimates bronchodilator response? Source: Eur Respir J 2003; 22: Suppl. 45, 100s Year: 2003 Assessment of the relationship between FEF25-75/FVC ratio and reversibility in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 810s Year: 2006